Wojcicki Regains 23andMe

News

Anne Wojcicki wins back 23andMe, this time

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday. WHY IT

· 21h · on MSN

Nonprofit run by former CEO Anne Wojcicki wins bid to acquire 23andMe

· 3d · on MSN

Anne Wojcicki Wins Bidding for 23andMe

16hon MSN

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

18hon MSN

Former 23andMe CEO Outbids Big Pharma to Regain Control of DNA Testing Firm

Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a ...

Axios on MSN21h

23andMe's former CEO agrees to buy the company for $305 million

Anne Wojcicki is poised to regain control of genetics testing company 23andMe, which she cofounded and led until earlier this ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results